Bicillin L-A Suspension For Injection 600000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Bicillin L-A: Suspension for injection (600000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Bicillin L-A 1,200,000unit/2ml
Drug Image file default-drug-image.png
Bicillin L-A 2,400,000/4ml Inj
Drug Image file default-drug-image.png
Bicillin L-A 600,000U/mL Inj

What is this Medicine?

PENICILLIN G BENZATHINE (pen i SILL in G BEN za thine) is a penicillin antibiotic. It is used to treat certain kinds of bacterial infections. It is also used to prevent a recurrence of rheumatic fever or Sydenham's chorea. It will not work for colds, flu, or other viral infections.

CVS Pharmacy Patient Statistics for Bicillin L-A: Suspension for injection(600000U)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Bicillin L-A 1,200,000units/2ml Suspension for Injection

NDC: 607930701
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Yaws, Pinta, Bejel, Upper Respiratory Tract Infections, Pharyngitis, Syphilis, Rheumatic Fever Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Bacterial Colonization Eradication, Neurosyphilis, Diphtheria Prophylaxis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from freezing
Bicillin L-A 1,200,000units/2ml Suspension for Injection

Reported Side Effects for Bicillin L-A 1,200,000units/2ml Suspension for Injection

Eosinophilia Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Bowel Necrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Inflamed Blood Vessels Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Red, Pimple Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Rash With Pustules Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Laryngeal Edema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Fever Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Exfoliative Dermatitis Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Swelling Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Serum Sickness Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
<5.0%*
Severity: MILD
Onset: RAPID
Pseudomembranous Colitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Superinfection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Tongue Discoloration Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Bicillin L-A

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5